SEC Company Response from Aptose Biosciences Inc. (CIK 0000882361) (APTOF) — Jan 7, 2020

Aptose Biosciences Inc. (CIK 0000882361)
Date: Jan. 7, 2020 · CIK: 0000882361 · Accession: 0000912282-20-000004

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-235730

Date

January 7, 2020

Author

Not clearly detected

Form

CORRESP

Company

Aptose Biosciences Inc. (CIK 0000882361)

Letter

Re: Aptose Biosciences Inc.

[LETTERHEAD OF APTOSE BIOSCIENCES INC.]

January 7, 2020

VIA EDGAR

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549-7010

USA

Registration Statement on Form S-3

Filed December 27, 2019

File No. 333-235730

Pursuant to Rule 461(a) under the Securities Act of 1933, as amended (the “Securities Act”), Aptose Biosciences Inc. (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement (the “Registration Statement”) to January 9, 2020 at 4:00 p.m. (Eastern) or as soon thereafter as is practicable.

The Company also requests the Commission confirm the effective date and time of the Registration Statement in writing.

APTOSE BIOSCIENCES INC.

By /s/ Gregory K. Chow

Name:

Gregory K. Chow

Title:

Executive Vice President & Chief Financial Officer

Show Raw Text

CORRESP
1
filename1.htm

    [LETTERHEAD OF APTOSE BIOSCIENCES INC.]

    January 7, 2020

            VIA EDGAR

            Securities and Exchange Commission

            100 F Street N.E.

            Washington, D.C.  20549-7010

            USA

    Re:         Aptose
        Biosciences Inc.

    Registration Statement on Form S-3

    Filed December 27, 2019

    File No. 333-235730

    Pursuant to Rule 461(a) under the Securities Act of 1933, as amended (the “Securities Act”), Aptose Biosciences Inc.
      (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement (the “Registration Statement”) to January 9, 2020 at 4:00 p.m.
      (Eastern) or as soon thereafter as is practicable.

    The Company also requests the Commission confirm the effective date and time of the Registration Statement in writing.

    APTOSE BIOSCIENCES INC.

    By                      /s/ Gregory K. Chow

            Name:

              Gregory K. Chow

              Title:

                Executive Vice President & Chief Financial Officer

SecProbe.io